nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—melanoma	0.17	0.411	CtDrD
Docetaxel—skin cancer—melanoma	0.139	0.336	CtDrD
Docetaxel—MAP2—melanoma	0.135	0.446	CbGaD
Docetaxel—lung cancer—melanoma	0.105	0.253	CtDrD
Docetaxel—BCL2—melanoma	0.0661	0.218	CbGaD
Docetaxel—CYP1B1—melanoma	0.0458	0.151	CbGaD
Docetaxel—EGFR—melanoma	0.0433	0.142	CbGaD
Docetaxel—ABCC1—Vemurafenib—melanoma	0.0383	0.299	CbGbCtD
Docetaxel—ABCG2—Vemurafenib—melanoma	0.0256	0.2	CbGbCtD
Docetaxel—ABCC1—Dactinomycin—melanoma	0.0254	0.199	CbGbCtD
Docetaxel—ABCG2—Dactinomycin—melanoma	0.017	0.133	CbGbCtD
Docetaxel—ABCB1—melanoma	0.0132	0.0433	CbGaD
Docetaxel—CYP3A4—Temozolomide—melanoma	0.0101	0.0788	CbGbCtD
Docetaxel—ABCB1—Dactinomycin—melanoma	0.00614	0.0479	CbGbCtD
Docetaxel—CYP3A4—Vemurafenib—melanoma	0.00553	0.0432	CbGbCtD
Docetaxel—Paclitaxel—MAP2—melanoma	0.00105	0.489	CrCbGaD
Docetaxel—MAP4—hair follicle—melanoma	0.00104	0.0486	CbGeAlD
Docetaxel—KIF11—mammalian vulva—melanoma	0.000896	0.0417	CbGeAlD
Docetaxel—GHRHR—head—melanoma	0.000754	0.0351	CbGeAlD
Docetaxel—TUBB4B—skin epidermis—melanoma	0.000694	0.0323	CbGeAlD
Docetaxel—MAPT—retina—melanoma	0.000656	0.0306	CbGeAlD
Docetaxel—BCL2—neck—melanoma	0.000636	0.0296	CbGeAlD
Docetaxel—TUBB—hair follicle—melanoma	0.000581	0.027	CbGeAlD
Docetaxel—MAP2—neck—melanoma	0.000551	0.0257	CbGeAlD
Docetaxel—MAP4—eye—melanoma	0.000521	0.0242	CbGeAlD
Docetaxel—MAP4—retina—melanoma	0.000516	0.024	CbGeAlD
Docetaxel—Paclitaxel—BCL2—melanoma	0.000513	0.239	CrCbGaD
Docetaxel—TUBB4B—hair follicle—melanoma	0.000495	0.0231	CbGeAlD
Docetaxel—MAP4—skin of body—melanoma	0.000453	0.0211	CbGeAlD
Docetaxel—NR1I2—head—melanoma	0.000452	0.021	CbGeAlD
Docetaxel—KIF11—lymph node—melanoma	0.000449	0.0209	CbGeAlD
Docetaxel—TUBB8—head—melanoma	0.000433	0.0202	CbGeAlD
Docetaxel—BCL2—skin of body—melanoma	0.000412	0.0192	CbGeAlD
Docetaxel—MAP2—eye—melanoma	0.00041	0.0191	CbGeAlD
Docetaxel—MAP2—retina—melanoma	0.000406	0.0189	CbGeAlD
Docetaxel—CYP1B1—hair follicle—melanoma	0.000392	0.0183	CbGeAlD
Docetaxel—EGFR—mammalian vulva—melanoma	0.000371	0.0173	CbGeAlD
Docetaxel—Paclitaxel—CYP1B1—melanoma	0.000355	0.166	CrCbGaD
Docetaxel—ABCC1—hair follicle—melanoma	0.000353	0.0164	CbGeAlD
Docetaxel—MAP2—mammalian vulva—melanoma	0.000325	0.0151	CbGeAlD
Docetaxel—TUBB4A—eye—melanoma	0.000317	0.0148	CbGeAlD
Docetaxel—TUBB4A—retina—melanoma	0.000314	0.0146	CbGeAlD
Docetaxel—TUBB2B—eye—melanoma	0.000306	0.0143	CbGeAlD
Docetaxel—TUBB2B—retina—melanoma	0.000304	0.0141	CbGeAlD
Docetaxel—TUBB3—head—melanoma	0.000296	0.0138	CbGeAlD
Docetaxel—MAP4—head—melanoma	0.000296	0.0138	CbGeAlD
Docetaxel—TUBB1—head—melanoma	0.000289	0.0135	CbGeAlD
Docetaxel—TUBB2A—eye—melanoma	0.000288	0.0134	CbGeAlD
Docetaxel—TUBB4A—skin of body—melanoma	0.000276	0.0128	CbGeAlD
Docetaxel—BCL2—head—melanoma	0.000269	0.0125	CbGeAlD
Docetaxel—MAPT—lymph node—melanoma	0.000263	0.0123	CbGeAlD
Docetaxel—TUBB2A—skin of body—melanoma	0.000251	0.0117	CbGeAlD
Docetaxel—TUBB6—skin of body—melanoma	0.000247	0.0115	CbGeAlD
Docetaxel—TUBB4B—eye—melanoma	0.000247	0.0115	CbGeAlD
Docetaxel—TUBB4B—retina—melanoma	0.000245	0.0114	CbGeAlD
Docetaxel—TUBB2B—mammalian vulva—melanoma	0.000243	0.0113	CbGeAlD
Docetaxel—MAP2—head—melanoma	0.000233	0.0108	CbGeAlD
Docetaxel—TUBB—mammalian vulva—melanoma	0.00023	0.0107	CbGeAlD
Docetaxel—TUBB2A—mammalian vulva—melanoma	0.000229	0.0106	CbGeAlD
Docetaxel—TUBB6—mammalian vulva—melanoma	0.000226	0.0105	CbGeAlD
Docetaxel—TUBB4B—skin of body—melanoma	0.000215	0.01	CbGeAlD
Docetaxel—MAP4—lymph node—melanoma	0.000207	0.00964	CbGeAlD
Docetaxel—ABCC10—mammalian vulva—melanoma	0.000198	0.0092	CbGeAlD
Docetaxel—TUBB4B—mammalian vulva—melanoma	0.000196	0.00913	CbGeAlD
Docetaxel—CYP1B1—eye—melanoma	0.000196	0.00911	CbGeAlD
Docetaxel—BCL2—lymph node—melanoma	0.000188	0.00876	CbGeAlD
Docetaxel—EGFR—lymph node—melanoma	0.000186	0.00866	CbGeAlD
Docetaxel—TUBB4A—head—melanoma	0.00018	0.00837	CbGeAlD
Docetaxel—TUBB2B—head—melanoma	0.000174	0.00809	CbGeAlD
Docetaxel—CYP1B1—skin of body—melanoma	0.00017	0.00793	CbGeAlD
Docetaxel—TUBB2A—head—melanoma	0.000164	0.00762	CbGeAlD
Docetaxel—MAP2—lymph node—melanoma	0.000163	0.00759	CbGeAlD
Docetaxel—TUBB6—head—melanoma	0.000161	0.00751	CbGeAlD
Docetaxel—TUBB4B—head—melanoma	0.00014	0.00653	CbGeAlD
Docetaxel—ABCC1—mammalian vulva—melanoma	0.00014	0.0065	CbGeAlD
Docetaxel—ABCB1—blood vessel—melanoma	0.000135	0.00629	CbGeAlD
Docetaxel—Menopausal symptoms—Temozolomide—melanoma	0.000128	0.00218	CcSEcCtD
Docetaxel—Cabazitaxel—ABCB1—melanoma	0.000126	0.0588	CrCbGaD
Docetaxel—TUBB4A—lymph node—melanoma	0.000126	0.00586	CbGeAlD
Docetaxel—Hyponatraemia—Carmustine—melanoma	0.000125	0.00213	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000125	0.00212	CcSEcCtD
Docetaxel—Cough—Vemurafenib—melanoma	0.000124	0.00211	CcSEcCtD
Docetaxel—Liver function test abnormal—Dactinomycin—melanoma	0.000123	0.0021	CcSEcCtD
Docetaxel—TUBB2B—lymph node—melanoma	0.000122	0.00567	CbGeAlD
Docetaxel—Bronchospasm—Bleomycin—melanoma	0.000122	0.00207	CcSEcCtD
Docetaxel—Myalgia—Vemurafenib—melanoma	0.000121	0.00206	CcSEcCtD
Docetaxel—Arthralgia—Vemurafenib—melanoma	0.000121	0.00206	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00012	0.00205	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00012	0.00204	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00012	0.00204	CcSEcCtD
Docetaxel—Pancytopenia—Bleomycin—melanoma	0.000117	0.002	CcSEcCtD
Docetaxel—Ataxia—Carmustine—melanoma	0.000117	0.002	CcSEcCtD
Docetaxel—Anaphylactic shock—Vemurafenib—melanoma	0.000116	0.00197	CcSEcCtD
Docetaxel—ABCG2—mammalian vulva—melanoma	0.000116	0.00539	CbGeAlD
Docetaxel—Dysphagia—Dactinomycin—melanoma	0.000115	0.00196	CcSEcCtD
Docetaxel—Infection—Vemurafenib—melanoma	0.000115	0.00196	CcSEcCtD
Docetaxel—Liver function test abnormal—Carmustine—melanoma	0.000115	0.00196	CcSEcCtD
Docetaxel—TUBB—lymph node—melanoma	0.000115	0.00536	CbGeAlD
Docetaxel—TUBB2A—lymph node—melanoma	0.000115	0.00534	CbGeAlD
Docetaxel—Nervous system disorder—Vemurafenib—melanoma	0.000114	0.00194	CcSEcCtD
Docetaxel—Ataxia—Temozolomide—melanoma	0.000114	0.00193	CcSEcCtD
Docetaxel—TUBB6—lymph node—melanoma	0.000113	0.00526	CbGeAlD
Docetaxel—Skin disorder—Vemurafenib—melanoma	0.000113	0.00192	CcSEcCtD
Docetaxel—Dehydration—Temozolomide—melanoma	0.000112	0.00191	CcSEcCtD
Docetaxel—Weight decreased—Bleomycin—melanoma	0.000112	0.0019	CcSEcCtD
Docetaxel—CYP1B1—head—melanoma	0.000111	0.00517	CbGeAlD
Docetaxel—Pneumonia—Bleomycin—melanoma	0.000111	0.00189	CcSEcCtD
Docetaxel—Dry skin—Temozolomide—melanoma	0.000111	0.00188	CcSEcCtD
Docetaxel—Pancytopenia—Dactinomycin—melanoma	0.00011	0.00186	CcSEcCtD
Docetaxel—Breast disorder—Temozolomide—melanoma	0.000109	0.00186	CcSEcCtD
Docetaxel—Acute coronary syndrome—Bleomycin—melanoma	0.000109	0.00185	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000109	0.00185	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000109	0.00185	CcSEcCtD
Docetaxel—Hypotension—Vemurafenib—melanoma	0.000109	0.00185	CcSEcCtD
Docetaxel—Myocardial infarction—Bleomycin—melanoma	0.000108	0.00184	CcSEcCtD
Docetaxel—Dysphagia—Carmustine—melanoma	0.000108	0.00184	CcSEcCtD
Docetaxel—Neutropenia—Dactinomycin—melanoma	0.000108	0.00183	CcSEcCtD
Docetaxel—Stomatitis—Bleomycin—melanoma	0.000108	0.00183	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Temozolomide—melanoma	0.000106	0.00181	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000106	0.0018	CcSEcCtD
Docetaxel—Dysphagia—Temozolomide—melanoma	0.000104	0.00177	CcSEcCtD
Docetaxel—Pneumonia—Dactinomycin—melanoma	0.000103	0.00176	CcSEcCtD
Docetaxel—Pancytopenia—Carmustine—melanoma	0.000103	0.00174	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000102	0.00173	CcSEcCtD
Docetaxel—Paclitaxel—ABCB1—melanoma	0.000102	0.0475	CrCbGaD
Docetaxel—Neutropenia—Carmustine—melanoma	0.000101	0.00172	CcSEcCtD
Docetaxel—Decreased appetite—Vemurafenib—melanoma	0.000101	0.00172	CcSEcCtD
Docetaxel—Stomatitis—Dactinomycin—melanoma	0.0001	0.00171	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Vemurafenib—melanoma	0.0001	0.0017	CcSEcCtD
Docetaxel—Fatigue—Vemurafenib—melanoma	0.0001	0.0017	CcSEcCtD
Docetaxel—Haemoglobin—Bleomycin—melanoma	9.95e-05	0.00169	CcSEcCtD
Docetaxel—Constipation—Vemurafenib—melanoma	9.93e-05	0.00169	CcSEcCtD
Docetaxel—Pancytopenia—Temozolomide—melanoma	9.91e-05	0.00169	CcSEcCtD
Docetaxel—Haemorrhage—Bleomycin—melanoma	9.9e-05	0.00168	CcSEcCtD
Docetaxel—ABCC10—lymph node—melanoma	9.9e-05	0.00461	CbGeAlD
Docetaxel—Hypoaesthesia—Bleomycin—melanoma	9.85e-05	0.00168	CcSEcCtD
Docetaxel—TUBB4B—lymph node—melanoma	9.82e-05	0.00457	CbGeAlD
Docetaxel—Neutropenia—Temozolomide—melanoma	9.76e-05	0.00166	CcSEcCtD
Docetaxel—Pneumonia—Carmustine—melanoma	9.68e-05	0.00165	CcSEcCtD
Docetaxel—Agranulocytosis—Dactinomycin—melanoma	9.6e-05	0.00163	CcSEcCtD
Docetaxel—Weight increased—Temozolomide—melanoma	9.5e-05	0.00162	CcSEcCtD
Docetaxel—Renal failure—Carmustine—melanoma	9.46e-05	0.00161	CcSEcCtD
Docetaxel—Weight decreased—Temozolomide—melanoma	9.44e-05	0.00161	CcSEcCtD
Docetaxel—Neuropathy peripheral—Carmustine—melanoma	9.44e-05	0.00161	CcSEcCtD
Docetaxel—Stomatitis—Carmustine—melanoma	9.39e-05	0.0016	CcSEcCtD
Docetaxel—Pneumonia—Temozolomide—melanoma	9.36e-05	0.00159	CcSEcCtD
Docetaxel—Infestation NOS—Temozolomide—melanoma	9.3e-05	0.00158	CcSEcCtD
Docetaxel—Infestation—Temozolomide—melanoma	9.3e-05	0.00158	CcSEcCtD
Docetaxel—Hepatitis—Dactinomycin—melanoma	9.23e-05	0.00157	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Temozolomide—melanoma	9.22e-05	0.00157	CcSEcCtD
Docetaxel—Flushing—Bleomycin—melanoma	9.19e-05	0.00156	CcSEcCtD
Docetaxel—Body temperature increased—Vemurafenib—melanoma	9.18e-05	0.00156	CcSEcCtD
Docetaxel—Pharyngitis—Dactinomycin—melanoma	9.17e-05	0.00156	CcSEcCtD
Docetaxel—Neuropathy peripheral—Temozolomide—melanoma	9.12e-05	0.00155	CcSEcCtD
Docetaxel—Stomatitis—Temozolomide—melanoma	9.07e-05	0.00154	CcSEcCtD
Docetaxel—Chills—Bleomycin—melanoma	8.88e-05	0.00151	CcSEcCtD
Docetaxel—Hepatobiliary disease—Temozolomide—melanoma	8.8e-05	0.0015	CcSEcCtD
Docetaxel—Alopecia—Bleomycin—melanoma	8.75e-05	0.00149	CcSEcCtD
Docetaxel—Erythema multiforme—Dactinomycin—melanoma	8.73e-05	0.00148	CcSEcCtD
Docetaxel—Haemoglobin—Carmustine—melanoma	8.69e-05	0.00148	CcSEcCtD
Docetaxel—Haemorrhage—Carmustine—melanoma	8.64e-05	0.00147	CcSEcCtD
Docetaxel—Erythema—Bleomycin—melanoma	8.62e-05	0.00147	CcSEcCtD
Docetaxel—Hypoaesthesia—Carmustine—melanoma	8.6e-05	0.00146	CcSEcCtD
Docetaxel—Flushing—Dactinomycin—melanoma	8.57e-05	0.00146	CcSEcCtD
Docetaxel—Hypersensitivity—Vemurafenib—melanoma	8.55e-05	0.00145	CcSEcCtD
Docetaxel—Oedema peripheral—Carmustine—melanoma	8.51e-05	0.00145	CcSEcCtD
Docetaxel—Connective tissue disorder—Carmustine—melanoma	8.49e-05	0.00144	CcSEcCtD
Docetaxel—Haemoglobin—Temozolomide—melanoma	8.4e-05	0.00143	CcSEcCtD
Docetaxel—Hepatitis—Temozolomide—melanoma	8.35e-05	0.00142	CcSEcCtD
Docetaxel—Haemorrhage—Temozolomide—melanoma	8.35e-05	0.00142	CcSEcCtD
Docetaxel—Asthenia—Vemurafenib—melanoma	8.33e-05	0.00142	CcSEcCtD
Docetaxel—Visual impairment—Carmustine—melanoma	8.33e-05	0.00142	CcSEcCtD
Docetaxel—Hypoaesthesia—Temozolomide—melanoma	8.31e-05	0.00141	CcSEcCtD
Docetaxel—Pharyngitis—Temozolomide—melanoma	8.29e-05	0.00141	CcSEcCtD
Docetaxel—Chills—Dactinomycin—melanoma	8.29e-05	0.00141	CcSEcCtD
Docetaxel—Urinary tract disorder—Temozolomide—melanoma	8.25e-05	0.0014	CcSEcCtD
Docetaxel—Oedema peripheral—Temozolomide—melanoma	8.23e-05	0.0014	CcSEcCtD
Docetaxel—Pruritus—Vemurafenib—melanoma	8.22e-05	0.0014	CcSEcCtD
Docetaxel—Connective tissue disorder—Temozolomide—melanoma	8.21e-05	0.0014	CcSEcCtD
Docetaxel—Urethral disorder—Temozolomide—melanoma	8.19e-05	0.00139	CcSEcCtD
Docetaxel—Alopecia—Dactinomycin—melanoma	8.16e-05	0.00139	CcSEcCtD
Docetaxel—Eye disorder—Carmustine—melanoma	8.08e-05	0.00137	CcSEcCtD
Docetaxel—Visual impairment—Temozolomide—melanoma	8.05e-05	0.00137	CcSEcCtD
Docetaxel—Erythema—Dactinomycin—melanoma	8.04e-05	0.00137	CcSEcCtD
Docetaxel—Flushing—Carmustine—melanoma	8.02e-05	0.00136	CcSEcCtD
Docetaxel—Anaemia—Bleomycin—melanoma	7.97e-05	0.00135	CcSEcCtD
Docetaxel—ABCC2—lymph node—melanoma	7.95e-05	0.0037	CbGeAlD
Docetaxel—Diarrhoea—Vemurafenib—melanoma	7.94e-05	0.00135	CcSEcCtD
Docetaxel—Erythema multiforme—Temozolomide—melanoma	7.9e-05	0.00134	CcSEcCtD
Docetaxel—Eye disorder—Temozolomide—melanoma	7.81e-05	0.00133	CcSEcCtD
Docetaxel—CYP1B1—lymph node—melanoma	7.78e-05	0.00362	CbGeAlD
Docetaxel—Cardiac disorder—Temozolomide—melanoma	7.75e-05	0.00132	CcSEcCtD
Docetaxel—Flushing—Temozolomide—melanoma	7.75e-05	0.00132	CcSEcCtD
Docetaxel—Arrhythmia—Carmustine—melanoma	7.72e-05	0.00131	CcSEcCtD
Docetaxel—Leukopenia—Bleomycin—melanoma	7.72e-05	0.00131	CcSEcCtD
Docetaxel—Dizziness—Vemurafenib—melanoma	7.68e-05	0.00131	CcSEcCtD
Docetaxel—Alopecia—Carmustine—melanoma	7.64e-05	0.0013	CcSEcCtD
Docetaxel—Angiopathy—Temozolomide—melanoma	7.58e-05	0.00129	CcSEcCtD
Docetaxel—Mental disorder—Carmustine—melanoma	7.57e-05	0.00129	CcSEcCtD
Docetaxel—Immune system disorder—Temozolomide—melanoma	7.54e-05	0.00128	CcSEcCtD
Docetaxel—Mediastinal disorder—Temozolomide—melanoma	7.53e-05	0.00128	CcSEcCtD
Docetaxel—Malnutrition—Carmustine—melanoma	7.52e-05	0.00128	CcSEcCtD
Docetaxel—Erythema—Carmustine—melanoma	7.52e-05	0.00128	CcSEcCtD
Docetaxel—Cough—Bleomycin—melanoma	7.52e-05	0.00128	CcSEcCtD
Docetaxel—Chills—Temozolomide—melanoma	7.49e-05	0.00127	CcSEcCtD
Docetaxel—Anaemia—Dactinomycin—melanoma	7.43e-05	0.00126	CcSEcCtD
Docetaxel—Vomiting—Vemurafenib—melanoma	7.38e-05	0.00126	CcSEcCtD
Docetaxel—Alopecia—Temozolomide—melanoma	7.38e-05	0.00126	CcSEcCtD
Docetaxel—Myalgia—Bleomycin—melanoma	7.34e-05	0.00125	CcSEcCtD
Docetaxel—Chest pain—Bleomycin—melanoma	7.34e-05	0.00125	CcSEcCtD
Docetaxel—Rash—Vemurafenib—melanoma	7.32e-05	0.00125	CcSEcCtD
Docetaxel—Mental disorder—Temozolomide—melanoma	7.32e-05	0.00124	CcSEcCtD
Docetaxel—Dermatitis—Vemurafenib—melanoma	7.31e-05	0.00124	CcSEcCtD
Docetaxel—Back pain—Carmustine—melanoma	7.28e-05	0.00124	CcSEcCtD
Docetaxel—Headache—Vemurafenib—melanoma	7.27e-05	0.00124	CcSEcCtD
Docetaxel—Erythema—Temozolomide—melanoma	7.27e-05	0.00124	CcSEcCtD
Docetaxel—Malnutrition—Temozolomide—melanoma	7.27e-05	0.00124	CcSEcCtD
Docetaxel—Leukopenia—Dactinomycin—melanoma	7.2e-05	0.00122	CcSEcCtD
Docetaxel—ABCB1—retina—melanoma	7.12e-05	0.00332	CbGeAlD
Docetaxel—Dysgeusia—Temozolomide—melanoma	7.12e-05	0.00121	CcSEcCtD
Docetaxel—Confusional state—Bleomycin—melanoma	7.09e-05	0.00121	CcSEcCtD
Docetaxel—Oedema—Bleomycin—melanoma	7.03e-05	0.0012	CcSEcCtD
Docetaxel—Anaphylactic shock—Bleomycin—melanoma	7.03e-05	0.0012	CcSEcCtD
Docetaxel—Back pain—Temozolomide—melanoma	7.03e-05	0.0012	CcSEcCtD
Docetaxel—ABCC1—lymph node—melanoma	7e-05	0.00326	CbGeAlD
Docetaxel—Infection—Bleomycin—melanoma	6.99e-05	0.00119	CcSEcCtD
Docetaxel—Anaemia—Carmustine—melanoma	6.95e-05	0.00118	CcSEcCtD
Docetaxel—Nausea—Vemurafenib—melanoma	6.9e-05	0.00117	CcSEcCtD
Docetaxel—Thrombocytopenia—Bleomycin—melanoma	6.89e-05	0.00117	CcSEcCtD
Docetaxel—Myalgia—Dactinomycin—melanoma	6.84e-05	0.00116	CcSEcCtD
Docetaxel—Leukopenia—Carmustine—melanoma	6.74e-05	0.00115	CcSEcCtD
Docetaxel—Anaemia—Temozolomide—melanoma	6.72e-05	0.00114	CcSEcCtD
Docetaxel—Anorexia—Bleomycin—melanoma	6.71e-05	0.00114	CcSEcCtD
Docetaxel—Hypotension—Bleomycin—melanoma	6.57e-05	0.00112	CcSEcCtD
Docetaxel—Oedema—Dactinomycin—melanoma	6.56e-05	0.00112	CcSEcCtD
Docetaxel—Convulsion—Carmustine—melanoma	6.52e-05	0.00111	CcSEcCtD
Docetaxel—Infection—Dactinomycin—melanoma	6.52e-05	0.00111	CcSEcCtD
Docetaxel—Leukopenia—Temozolomide—melanoma	6.51e-05	0.00111	CcSEcCtD
Docetaxel—Hypertension—Carmustine—melanoma	6.5e-05	0.0011	CcSEcCtD
Docetaxel—Palpitations—Temozolomide—melanoma	6.43e-05	0.00109	CcSEcCtD
Docetaxel—Thrombocytopenia—Dactinomycin—melanoma	6.42e-05	0.00109	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Bleomycin—melanoma	6.41e-05	0.00109	CcSEcCtD
Docetaxel—Myalgia—Carmustine—melanoma	6.41e-05	0.00109	CcSEcCtD
Docetaxel—Chest pain—Carmustine—melanoma	6.41e-05	0.00109	CcSEcCtD
Docetaxel—Cough—Temozolomide—melanoma	6.34e-05	0.00108	CcSEcCtD
Docetaxel—Paraesthesia—Bleomycin—melanoma	6.32e-05	0.00107	CcSEcCtD
Docetaxel—Convulsion—Temozolomide—melanoma	6.3e-05	0.00107	CcSEcCtD
Docetaxel—Hypertension—Temozolomide—melanoma	6.28e-05	0.00107	CcSEcCtD
Docetaxel—Dyspnoea—Bleomycin—melanoma	6.27e-05	0.00107	CcSEcCtD
Docetaxel—Anorexia—Dactinomycin—melanoma	6.25e-05	0.00106	CcSEcCtD
Docetaxel—Confusional state—Carmustine—melanoma	6.19e-05	0.00105	CcSEcCtD
Docetaxel—Arthralgia—Temozolomide—melanoma	6.19e-05	0.00105	CcSEcCtD
Docetaxel—Myalgia—Temozolomide—melanoma	6.19e-05	0.00105	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	6.15e-05	0.00105	CcSEcCtD
Docetaxel—Oedema—Carmustine—melanoma	6.14e-05	0.00104	CcSEcCtD
Docetaxel—Decreased appetite—Bleomycin—melanoma	6.12e-05	0.00104	CcSEcCtD
Docetaxel—Infection—Carmustine—melanoma	6.1e-05	0.00104	CcSEcCtD
Docetaxel—Dry mouth—Temozolomide—melanoma	6.05e-05	0.00103	CcSEcCtD
Docetaxel—Pain—Bleomycin—melanoma	6.02e-05	0.00102	CcSEcCtD
Docetaxel—Thrombocytopenia—Carmustine—melanoma	6.01e-05	0.00102	CcSEcCtD
Docetaxel—Tachycardia—Carmustine—melanoma	5.99e-05	0.00102	CcSEcCtD
Docetaxel—Confusional state—Temozolomide—melanoma	5.98e-05	0.00102	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Dactinomycin—melanoma	5.98e-05	0.00102	CcSEcCtD
Docetaxel—Oedema—Temozolomide—melanoma	5.93e-05	0.00101	CcSEcCtD
Docetaxel—Anaphylactic shock—Temozolomide—melanoma	5.93e-05	0.00101	CcSEcCtD
Docetaxel—Infection—Temozolomide—melanoma	5.9e-05	0.001	CcSEcCtD
Docetaxel—Anorexia—Carmustine—melanoma	5.85e-05	0.000995	CcSEcCtD
Docetaxel—Nervous system disorder—Temozolomide—melanoma	5.82e-05	0.00099	CcSEcCtD
Docetaxel—Thrombocytopenia—Temozolomide—melanoma	5.81e-05	0.000988	CcSEcCtD
Docetaxel—Feeling abnormal—Bleomycin—melanoma	5.8e-05	0.000986	CcSEcCtD
Docetaxel—ABCG2—lymph node—melanoma	5.79e-05	0.0027	CbGeAlD
Docetaxel—Skin disorder—Temozolomide—melanoma	5.76e-05	0.00098	CcSEcCtD
Docetaxel—Hypotension—Carmustine—melanoma	5.74e-05	0.000976	CcSEcCtD
Docetaxel—ABCB1—mammalian vulva—melanoma	5.7e-05	0.00266	CbGeAlD
Docetaxel—Decreased appetite—Dactinomycin—melanoma	5.7e-05	0.00097	CcSEcCtD
Docetaxel—Fatigue—Dactinomycin—melanoma	5.66e-05	0.000962	CcSEcCtD
Docetaxel—Anorexia—Temozolomide—melanoma	5.66e-05	0.000962	CcSEcCtD
Docetaxel—Pain—Dactinomycin—melanoma	5.61e-05	0.000954	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Carmustine—melanoma	5.59e-05	0.000951	CcSEcCtD
Docetaxel—Body temperature increased—Bleomycin—melanoma	5.56e-05	0.000946	CcSEcCtD
Docetaxel—Insomnia—Carmustine—melanoma	5.55e-05	0.000945	CcSEcCtD
Docetaxel—Paraesthesia—Carmustine—melanoma	5.51e-05	0.000938	CcSEcCtD
Docetaxel—Dyspnoea—Carmustine—melanoma	5.47e-05	0.000931	CcSEcCtD
Docetaxel—Somnolence—Carmustine—melanoma	5.46e-05	0.000928	CcSEcCtD
Docetaxel—Feeling abnormal—Dactinomycin—melanoma	5.41e-05	0.00092	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Temozolomide—melanoma	5.41e-05	0.000919	CcSEcCtD
Docetaxel—Insomnia—Temozolomide—melanoma	5.37e-05	0.000913	CcSEcCtD
Docetaxel—Gastrointestinal pain—Dactinomycin—melanoma	5.37e-05	0.000912	CcSEcCtD
Docetaxel—Decreased appetite—Carmustine—melanoma	5.34e-05	0.000908	CcSEcCtD
Docetaxel—Paraesthesia—Temozolomide—melanoma	5.33e-05	0.000906	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Carmustine—melanoma	5.3e-05	0.000902	CcSEcCtD
Docetaxel—Dyspnoea—Temozolomide—melanoma	5.29e-05	0.0009	CcSEcCtD
Docetaxel—Somnolence—Temozolomide—melanoma	5.28e-05	0.000897	CcSEcCtD
Docetaxel—Pain—Carmustine—melanoma	5.25e-05	0.000893	CcSEcCtD
Docetaxel—Constipation—Carmustine—melanoma	5.25e-05	0.000893	CcSEcCtD
Docetaxel—Dyspepsia—Temozolomide—melanoma	5.22e-05	0.000888	CcSEcCtD
Docetaxel—Body temperature increased—Dactinomycin—melanoma	5.19e-05	0.000882	CcSEcCtD
Docetaxel—Abdominal pain—Dactinomycin—melanoma	5.19e-05	0.000882	CcSEcCtD
Docetaxel—Hypersensitivity—Bleomycin—melanoma	5.18e-05	0.000881	CcSEcCtD
Docetaxel—Decreased appetite—Temozolomide—melanoma	5.16e-05	0.000877	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Temozolomide—melanoma	5.12e-05	0.000871	CcSEcCtD
Docetaxel—Fatigue—Temozolomide—melanoma	5.12e-05	0.00087	CcSEcCtD
Docetaxel—Pain—Temozolomide—melanoma	5.07e-05	0.000863	CcSEcCtD
Docetaxel—Constipation—Temozolomide—melanoma	5.07e-05	0.000863	CcSEcCtD
Docetaxel—Feeling abnormal—Carmustine—melanoma	5.06e-05	0.000861	CcSEcCtD
Docetaxel—Asthenia—Bleomycin—melanoma	5.05e-05	0.000858	CcSEcCtD
Docetaxel—Gastrointestinal pain—Carmustine—melanoma	5.02e-05	0.000854	CcSEcCtD
Docetaxel—Pruritus—Bleomycin—melanoma	4.98e-05	0.000846	CcSEcCtD
Docetaxel—Feeling abnormal—Temozolomide—melanoma	4.89e-05	0.000832	CcSEcCtD
Docetaxel—Body temperature increased—Carmustine—melanoma	4.85e-05	0.000826	CcSEcCtD
Docetaxel—Abdominal pain—Carmustine—melanoma	4.85e-05	0.000826	CcSEcCtD
Docetaxel—Gastrointestinal pain—Temozolomide—melanoma	4.85e-05	0.000825	CcSEcCtD
Docetaxel—Hypersensitivity—Dactinomycin—melanoma	4.83e-05	0.000822	CcSEcCtD
Docetaxel—Asthenia—Dactinomycin—melanoma	4.71e-05	0.000801	CcSEcCtD
Docetaxel—Abdominal pain—Temozolomide—melanoma	4.69e-05	0.000798	CcSEcCtD
Docetaxel—Body temperature increased—Temozolomide—melanoma	4.69e-05	0.000798	CcSEcCtD
Docetaxel—Hypersensitivity—Carmustine—melanoma	4.52e-05	0.000769	CcSEcCtD
Docetaxel—Diarrhoea—Dactinomycin—melanoma	4.49e-05	0.000763	CcSEcCtD
Docetaxel—Vomiting—Bleomycin—melanoma	4.47e-05	0.000761	CcSEcCtD
Docetaxel—Rash—Bleomycin—melanoma	4.44e-05	0.000754	CcSEcCtD
Docetaxel—Dermatitis—Bleomycin—melanoma	4.43e-05	0.000754	CcSEcCtD
Docetaxel—Asthenia—Carmustine—melanoma	4.41e-05	0.000749	CcSEcCtD
Docetaxel—Hypersensitivity—Temozolomide—melanoma	4.37e-05	0.000744	CcSEcCtD
Docetaxel—Asthenia—Temozolomide—melanoma	4.26e-05	0.000724	CcSEcCtD
Docetaxel—Diarrhoea—Carmustine—melanoma	4.2e-05	0.000715	CcSEcCtD
Docetaxel—Pruritus—Temozolomide—melanoma	4.2e-05	0.000714	CcSEcCtD
Docetaxel—Nausea—Bleomycin—melanoma	4.18e-05	0.000711	CcSEcCtD
Docetaxel—Vomiting—Dactinomycin—melanoma	4.17e-05	0.000709	CcSEcCtD
Docetaxel—Rash—Dactinomycin—melanoma	4.14e-05	0.000704	CcSEcCtD
Docetaxel—ABCB1—head—melanoma	4.08e-05	0.0019	CbGeAlD
Docetaxel—Dizziness—Carmustine—melanoma	4.06e-05	0.000691	CcSEcCtD
Docetaxel—Diarrhoea—Temozolomide—melanoma	4.06e-05	0.000691	CcSEcCtD
Docetaxel—Dizziness—Temozolomide—melanoma	3.92e-05	0.000667	CcSEcCtD
Docetaxel—Vomiting—Carmustine—melanoma	3.9e-05	0.000664	CcSEcCtD
Docetaxel—Nausea—Dactinomycin—melanoma	3.9e-05	0.000663	CcSEcCtD
Docetaxel—Rash—Carmustine—melanoma	3.87e-05	0.000658	CcSEcCtD
Docetaxel—Dermatitis—Carmustine—melanoma	3.87e-05	0.000658	CcSEcCtD
Docetaxel—Headache—Carmustine—melanoma	3.85e-05	0.000654	CcSEcCtD
Docetaxel—Vomiting—Temozolomide—melanoma	3.77e-05	0.000642	CcSEcCtD
Docetaxel—Rash—Temozolomide—melanoma	3.74e-05	0.000636	CcSEcCtD
Docetaxel—Dermatitis—Temozolomide—melanoma	3.74e-05	0.000636	CcSEcCtD
Docetaxel—Headache—Temozolomide—melanoma	3.72e-05	0.000632	CcSEcCtD
Docetaxel—Nausea—Carmustine—melanoma	3.65e-05	0.00062	CcSEcCtD
Docetaxel—Nausea—Temozolomide—melanoma	3.52e-05	0.000599	CcSEcCtD
Docetaxel—ABCB1—lymph node—melanoma	2.86e-05	0.00133	CbGeAlD
Docetaxel—EGFR—Signaling Pathways—EDN1—melanoma	1.26e-06	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CD—melanoma	1.26e-06	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—melanoma	1.25e-06	1.74e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1B1—melanoma	1.25e-06	1.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—melanoma	1.24e-06	1.73e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAP2K1—melanoma	1.24e-06	1.73e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CD—melanoma	1.23e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CSF2—melanoma	1.23e-06	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF1—melanoma	1.23e-06	1.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.23e-06	1.71e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—melanoma	1.23e-06	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—E2F1—melanoma	1.21e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGF2—melanoma	1.21e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—melanoma	1.2e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CB—melanoma	1.2e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—melanoma	1.2e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFRA—melanoma	1.19e-06	1.66e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.19e-06	1.66e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PHGDH—melanoma	1.19e-06	1.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LUM—melanoma	1.19e-06	1.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKCA—melanoma	1.18e-06	1.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ITGB3—melanoma	1.18e-06	1.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGF2—melanoma	1.18e-06	1.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—melanoma	1.17e-06	1.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAP2K1—melanoma	1.17e-06	1.63e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HPSE—melanoma	1.16e-06	1.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CD—melanoma	1.16e-06	1.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—melanoma	1.16e-06	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAP2K2—melanoma	1.16e-06	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—melanoma	1.15e-06	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—melanoma	1.15e-06	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—melanoma	1.15e-06	1.6e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.15e-06	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—melanoma	1.14e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CUBN—melanoma	1.14e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—melanoma	1.14e-06	1.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—melanoma	1.13e-06	1.58e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—melanoma	1.13e-06	1.58e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—melanoma	1.13e-06	1.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MDM2—melanoma	1.13e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP17A1—melanoma	1.12e-06	1.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGF2—melanoma	1.11e-06	1.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—melanoma	1.11e-06	1.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MDM2—melanoma	1.1e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SDHD—melanoma	1.1e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CSPG4—melanoma	1.1e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BSG—melanoma	1.1e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—melanoma	1.1e-06	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—melanoma	1.1e-06	1.53e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—melanoma	1.1e-06	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—melanoma	1.1e-06	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CB—melanoma	1.1e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—melanoma	1.1e-06	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAC1—melanoma	1.1e-06	1.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—melanoma	1.1e-06	1.52e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—melanoma	1.09e-06	1.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CB—melanoma	1.07e-06	1.5e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—melanoma	1.07e-06	1.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPAM—melanoma	1.07e-06	1.49e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—melanoma	1.06e-06	1.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—melanoma	1.06e-06	1.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—melanoma	1.06e-06	1.48e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNA11—melanoma	1.06e-06	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—melanoma	1.05e-06	1.46e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—melanoma	1.05e-06	1.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—melanoma	1.04e-06	1.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.04e-06	1.44e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—melanoma	1.03e-06	1.44e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—FASN—melanoma	1.03e-06	1.44e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—melanoma	1.03e-06	1.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—melanoma	1.03e-06	1.43e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—melanoma	1.03e-06	1.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—melanoma	1.03e-06	1.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—melanoma	1.02e-06	1.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—melanoma	1.02e-06	1.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—melanoma	1.02e-06	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—melanoma	1.02e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—melanoma	1.02e-06	1.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—melanoma	1.01e-06	1.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—melanoma	1.01e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—melanoma	1.01e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—melanoma	1.01e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—melanoma	1e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—melanoma	1e-06	1.4e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—melanoma	1e-06	1.39e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—melanoma	9.99e-07	1.39e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—melanoma	9.98e-07	1.39e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—melanoma	9.89e-07	1.38e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—melanoma	9.86e-07	1.37e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNAQ—melanoma	9.82e-07	1.37e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD44—melanoma	9.82e-07	1.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—melanoma	9.73e-07	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FN1—melanoma	9.67e-07	1.35e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—melanoma	9.53e-07	1.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—melanoma	9.51e-07	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—melanoma	9.5e-07	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—melanoma	9.48e-07	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH1—melanoma	9.47e-07	1.32e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PRKCA—melanoma	9.45e-07	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NFKB1—melanoma	9.44e-07	1.31e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1B1—melanoma	9.41e-07	1.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—melanoma	9.38e-07	1.3e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ERCC2—melanoma	9.38e-07	1.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—melanoma	9.31e-07	1.29e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—melanoma	9.29e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CD80—melanoma	9.27e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—melanoma	9.26e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—melanoma	9.26e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KIT—melanoma	9.26e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—melanoma	9.26e-07	1.29e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—melanoma	9.24e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EGF—melanoma	9.15e-07	1.27e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLA2G6—melanoma	9.09e-07	1.26e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—melanoma	9.09e-07	1.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—melanoma	9.01e-07	1.25e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—melanoma	9.01e-07	1.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—melanoma	9e-07	1.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—melanoma	8.98e-07	1.25e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—melanoma	8.97e-07	1.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—melanoma	8.92e-07	1.24e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—melanoma	8.89e-07	1.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—melanoma	8.87e-07	1.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—melanoma	8.77e-07	1.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—melanoma	8.75e-07	1.22e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—melanoma	8.71e-07	1.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—melanoma	8.7e-07	1.21e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—melanoma	8.63e-07	1.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—melanoma	8.48e-07	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1—melanoma	8.48e-07	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—melanoma	8.46e-07	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK1—melanoma	8.44e-07	1.17e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—melanoma	8.31e-07	1.16e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—melanoma	8.29e-07	1.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAP2K1—melanoma	8.19e-07	1.14e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—VCAN—melanoma	8.17e-07	1.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—melanoma	8.14e-07	1.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—melanoma	8.1e-07	1.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—melanoma	7.97e-07	1.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—melanoma	7.94e-07	1.1e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—melanoma	7.92e-07	1.1e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—melanoma	7.85e-07	1.09e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—melanoma	7.85e-07	1.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—melanoma	7.83e-07	1.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—melanoma	7.81e-07	1.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF2—melanoma	7.79e-07	1.08e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—melanoma	7.78e-07	1.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—melanoma	7.78e-07	1.08e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—melanoma	7.76e-07	1.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—melanoma	7.72e-07	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK1—melanoma	7.71e-07	1.07e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK1—melanoma	7.55e-07	1.05e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—melanoma	7.55e-07	1.05e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—melanoma	7.52e-07	1.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—melanoma	7.48e-07	1.04e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—melanoma	7.41e-07	1.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—melanoma	7.32e-07	1.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—melanoma	7.29e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—melanoma	7.28e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—melanoma	7.27e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—melanoma	7.19e-07	1e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—melanoma	7.15e-07	9.94e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PRKCA—melanoma	7.13e-07	9.92e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—melanoma	7.13e-07	9.92e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK1—melanoma	7.12e-07	9.9e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—melanoma	7.09e-07	9.87e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ERCC2—melanoma	7.08e-07	9.84e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP17A1—melanoma	6.89e-07	9.59e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—melanoma	6.84e-07	9.52e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—melanoma	6.82e-07	9.48e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—melanoma	6.78e-07	9.44e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—melanoma	6.77e-07	9.42e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—melanoma	6.72e-07	9.35e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—melanoma	6.69e-07	9.3e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—melanoma	6.66e-07	9.26e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—melanoma	6.55e-07	9.11e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—melanoma	6.52e-07	9.08e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—melanoma	6.51e-07	9.06e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—melanoma	6.51e-07	9.06e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNA11—melanoma	6.51e-07	9.05e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—melanoma	6.48e-07	9.02e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—melanoma	6.43e-07	8.94e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FASN—melanoma	6.37e-07	8.86e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—melanoma	6.35e-07	8.83e-06	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—melanoma	6.34e-07	8.82e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—melanoma	6.29e-07	8.75e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—melanoma	6.26e-07	8.71e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—melanoma	6.19e-07	8.61e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—melanoma	6.18e-07	8.59e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—melanoma	6.17e-07	8.58e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—melanoma	6.14e-07	8.55e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—melanoma	6.13e-07	8.53e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NFKB1—melanoma	6.1e-07	8.49e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—melanoma	6.06e-07	8.43e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNAQ—melanoma	6.05e-07	8.42e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD44—melanoma	6.05e-07	8.42e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—melanoma	5.98e-07	8.32e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—melanoma	5.92e-07	8.24e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—melanoma	5.8e-07	8.07e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1B1—melanoma	5.8e-07	8.07e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—melanoma	5.71e-07	7.95e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—melanoma	5.67e-07	7.89e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—melanoma	5.62e-07	7.82e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—melanoma	5.59e-07	7.77e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—melanoma	5.54e-07	7.7e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—melanoma	5.49e-07	7.63e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—melanoma	5.48e-07	7.63e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—melanoma	5.47e-07	7.61e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—melanoma	5.47e-07	7.61e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—melanoma	5.46e-07	7.6e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—melanoma	5.39e-07	7.5e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—melanoma	5.35e-07	7.45e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—melanoma	5.31e-07	7.38e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—melanoma	5.24e-07	7.29e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—melanoma	5.09e-07	7.09e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—melanoma	5.04e-07	7.02e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK1—melanoma	4.98e-07	6.93e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—melanoma	4.91e-07	6.83e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—melanoma	4.9e-07	6.82e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—melanoma	4.85e-07	6.75e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—melanoma	4.83e-07	6.72e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—melanoma	4.79e-07	6.66e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—melanoma	4.78e-07	6.64e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—melanoma	4.71e-07	6.55e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—melanoma	4.48e-07	6.24e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRKCA—melanoma	4.4e-07	6.11e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ERCC2—melanoma	4.36e-07	6.06e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—melanoma	4.34e-07	6.03e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—melanoma	4.32e-07	6.02e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—melanoma	4.28e-07	5.96e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—melanoma	4.24e-07	5.9e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—melanoma	4.18e-07	5.82e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—melanoma	4e-07	5.57e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—melanoma	3.94e-07	5.49e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—melanoma	3.91e-07	5.44e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—melanoma	3.83e-07	5.33e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—melanoma	3.7e-07	5.15e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—melanoma	3.53e-07	4.91e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—melanoma	3.46e-07	4.81e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—melanoma	3.44e-07	4.79e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—melanoma	3.32e-07	4.62e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—melanoma	3.03e-07	4.21e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—melanoma	2.99e-07	4.16e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—melanoma	2.83e-07	3.93e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—melanoma	2.64e-07	3.67e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—melanoma	2.61e-07	3.64e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—melanoma	2.61e-07	3.63e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—melanoma	2.28e-07	3.17e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—melanoma	2.13e-07	2.97e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—melanoma	1.61e-07	2.24e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—melanoma	1.31e-07	1.83e-06	CbGpPWpGaD
